Mr. Speaker, with the CETA deal officially signed and the legal scrub of the text having started, there are still some questions that remain unanswered. One such question surrounds the articles around patent protections for pharmaceutical products.
Can the government tell us what commitments it has made to compensate the provinces and territories as a result of the pharma provisions of CETA?